Trademark Overview
On Monday, March 17, 2025, a trademark application was filed for OPTIMIZATION-BY-DESIGN with the United States Patent and Trademark Office. The USPTO has given the OPTIMIZATION-BY-DESIGN trademark a serial number of 99087625. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 17, 2025. This trademark is owned by Andelyn Biosciences, Inc.. The OPTIMIZATION-BY-DESIGN trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents.
Pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products for use in the treatment of genetic diseases and disorders.
Business collaboration services, namely, providing a national computer-based networking web site for medical researchers to collaborate across disciplines to contract for development and manufacture of gene therapy and pharmaceutical products.
Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis in the nature of product testing and research and industrial research in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry; custom design and development of chemical reagents and biochemical assays; providing a computer software platform for users to access an integrated set of scientific ...
